AAAAAA
Results:
1-11
|
Results: 11
Authors:
Moller, MB
Nielsen, O
Pedersen, NT
Citation: Mb. Moller et al., Cyclin D3 expression in non-Hodgkin lymphoma - Correlation with other cellcycle regulators and clinical features, AM J CLIN P, 115(3), 2001, pp. 404-412
Authors:
McKelvie, D
Isard, A
Mengel, A
Moller, MB
Grosse, M
Klein, M
Citation: D. Mckelvie et al., The MATE workbench - An annotation tool for XML coded speech corpora, SPEECH COMM, 33(1-2), 2001, pp. 97-112
Authors:
Moller, MB
Citation: Mb. Moller, p27 in cell cycle control and cancer, LEUK LYMPH, 39(1-2), 2000, pp. 19-27
Authors:
Moller, MB
Kania, PW
Ino, Y
Gerdes, AM
Nielsen, O
Louis, DN
Skjodt, K
Pedersen, NT
Citation: Mb. Moller et al., Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16(INK4A), LEUKEMIA, 14(5), 2000, pp. 898-904
Authors:
Gronbaek, K
Brown, PD
Moller, MB
Nedergaard, T
Ralfkiaer, E
Moller, P
Zeuthen, J
Guldberg, P
Citation: K. Gronbaek et al., Concurrent disruption of p16(INK4a) and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma, LEUKEMIA, 14(10), 2000, pp. 1727-1735
Authors:
Hein, J
Wiuf, C
Knudsen, B
Moller, MB
Wibling, G
Citation: J. Hein et al., Statistical alignment: Computational properties, homology testing and goodness-of-fit, J MOL BIOL, 302(1), 2000, pp. 265-279
Authors:
Moller, MB
Gerdes, AM
Skjodt, K
Mortensen, LS
Pedersen, NT
Citation: Mb. Moller et al., Disrupted p53 function as predictor of treatment failure and poor prognosis in B- and T-cell non-Hodgkin's lymphoma, CLIN CANC R, 5(5), 1999, pp. 1085-1091
Authors:
Moller, MB
Nielsen, O
Pedersen, NT
Citation: Mb. Moller et al., Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities, MOD PATHOL, 12(11), 1999, pp. 1010-1016
Authors:
Moller, MB
Ino, Y
Gerdes, AM
Skjodt, K
Louis, DN
Pedersen, NT
Citation: Mb. Moller et al., Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma, LEUKEMIA, 13(3), 1999, pp. 453-459
Authors:
Moller, MB
Skjodt, K
Mortensen, LS
Pedersen, NT
Citation: Mb. Moller et al., Clinical significance of cyclin-dependent kinase inhibitor p27(Kip1) expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27(Kip1), BR J HAEM, 105(3), 1999, pp. 730-736
Authors:
Nielsen, GP
Stemmer-Rachamimov, AO
Ino, Y
Moller, MB
Rosenberg, AE
Louis, DN
Citation: Gp. Nielsen et al., Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation, AM J PATH, 155(6), 1999, pp. 1879-1884
Risultati:
1-11
|